A new strategic roadmap has been developed for conducting clinical trials in rare childhood central nervous system tumors, emphasizing the need for multi-stakeholder collaboration. This consensus aims to enhance trial delivery and improve outcomes for affected children.
strategic roadmap for delivery of clinical trials in rare childhood central nervous system cns tumours a multi stakeholder consensus
Original title: “Strategic roadmap for delivery of clinical trials in rare childhood central nervous system (CNS) tumours: a multi-stakeholder consensus.”